You are here

Sci Rep DOI:10.1038/srep34233

A rare schizophrenia risk variant of CACNA1I disrupts CaV3.3 channel activity.

Publication TypeJournal Article
Year of Publication2016
AuthorsAndrade, A, Hope, J, Allen, A, Yorgan, V, Lipscombe, D, Pan, JQ
JournalSci Rep
Date Published2016 Oct 19

CACNA1I is a candidate schizophrenia risk gene. It encodes the pore-forming human CaV3.3 α1 subunit, a subtype of voltage-gated calcium channel that contributes to T-type currents. Recently, two de novo missense variations, T797M and R1346H, of hCaV3.3 were identified in individuals with schizophrenia. Here we show that R1346H, but not T797M, is associated with lower hCaV3.3 protein levels, reduced glycosylation, and lower membrane surface levels of hCaV3.3 when expressed in human cell lines compared to wild-type. Consistent with our biochemical analyses, whole-cell hCaV3.3 currents in cells expressing the R1346H variant were ~50% of those in cells expressing WT hCaV3.3, and neither R1346H nor T797M altered channel biophysical properties. Employing the NEURON simulation environment, we found that reducing hCaV3.3 current densities by 22% or more eliminates rebound bursting in model thalamic reticular nucleus (TRN) neurons. Our analyses suggest that a single copy of Chr22: 39665939G > A CACNA1I has the capacity to disrupt CaV3.3 channel-dependent functions, including rebound bursting in TRN neurons, with potential implications for schizophrenia pathophysiology.


Alternate JournalSci Rep
PubMed ID27756899
PubMed Central IDPMC5069464
Grant ListT32 EY018080 / EY / NEI NIH HHS / United States
R21 MH099448 / MH / NIMH NIH HHS / United States
R00 MH099405 / MH / NIMH NIH HHS / United States
R01 NS055251 / NS / NINDS NIH HHS / United States
T32 NS062443 / NS / NINDS NIH HHS / United States